Article
Identification of a Gene Signature That Predicts Dependence upon YAP/TAZ-TEAD
2023-12-29
Abstract excerpt
Targeted therapies are effective cancer treatments when accompanied by accurate diagnostic tests that can help identify patients that will respond to those therapies. The YAP/TAZ-TEAD axis is activated and plays a causal role in several cancer types, and TEAD inhibitors are currently in early phase clinical trials in cancer patients. However, mutations that predict YAP/TAZ-TEAD activation are not commonly found in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- af4c7cd5-e035-5b74-8337-ae83cb3abe97
- DOI
- 10.20944/preprints202312.2314.v1
